How is Bio-Techne (TECH) doing?

Bio-Techne is a company in the biotechnology industry, based in Minneapolis, MN, worth $11.3B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

P3 score

Weak

Bio-Techne shares are up 20% over the past year, 3 points ahead of the S&P 500. Its type is Speculative Pop. Among large US stocks and funds it ranks in the 74th percentile on market beat, the 16th on staying power and the 15th on business growth. It appears on 6 of our dashboards.

$72.46+20% in a yearWorth $11.3B

Compare with TMO · DHR · RGEN · AVTR · RVTY · WAT

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

TECH against the S&P 500, past year

$100 a year ago. Bio-Techne +20%, the S&P 500 +16%.

TECHS&P 500

What kind of stock is it?

Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.

Speculative Pop

BeatingErraticSlowingBought

Beating the market with buyers piling in, but erratically, and its business growth trails most.

NovDecJanFebMarAprMayJunJulAugSepNow

Speculative Pop since Sep; Faith Trade before that.

Also Speculative Pop (69 in all): MTD · TMO · RPRX · DVA · BMY · BIO

EmbracedToppingAccumulatingRejectedStable rankBellwetherDistribution TopCoiled SpringWallflowerHolding rankFaith TradeRolling OverBottom FishedSleepy StapleUnsteady rankHot HandChurning WinnerTurning UpShow-Me GrowerBouncy rankSpeculative PopExhausted RallyFalling KnifeBroken Year

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

TECH, past year+20%40 of 86 in the group

Rest of the group+20%equal-weighted

S&P 500+16%past year

Bio-Techne is +20% over the past year, against +20% for the rest of the group and +16% for the S&P 500. It ranks 40th of 86 in Health care.

TECHRest of the group

Best in the groupRVMD Revolution Medicines+297%ILMN Illumina+184%NTRA Natera+133%

Worst in the groupPODD Insulet−57%BSX Boston Scientific−56%RARE Ultragenyx−50%

Its closest rivalsTMO Thermo Fisher Scientific+23%DHR Danaher+7%RGEN Repligen+15%AVTR Avantor+14%RVTY Revvity+68%

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

Calmer than usual Bio-Techne typically moves 0.3% in a day, calmer than usual for it, and it swings more than 55% of large US stocks.

Typical day0.3%about $0.18 a share

Its usual3.2%calmer than usual, 0.1× its year’s average

Against the S&P 5002.9×the index’s typical day is 1.1%

Unusual day±0.5%twice its typical day

Deepest fall, past year−39%at its high

In the S&P’s down weeks122%of the index’s fall, three years; beta 0.9

Typical daily move (ATR)Its year’s average 3.25%

TECH on our dashboards

Every question where Bio-Techne appears, in the order of the home page, with its reading and place in that table. Select a question to open it with TECH highlighted. Select a column to sort.

Question	Reading	Place	Details
Which stocks are setting new highs? Market health	68	27 of 31	1Y +20% · 3M +2% · Days at a high 7
Which companies are most exposed to China? The economy and rates	0Light	35 of 35	Share of sales 0.0% · China sales $0 · 3-year change 0 pts
Which stocks keep winning? Leading stocks	9031 of 52 wks	52 of 60	vs S&P, 1Y +4 pts · Rank steadiness 16 · P3 score 26
Whose profit margins are widening? Business quality	95Widening	20 of 60	Change, 1Y +12.3 pts · Operating margin 21% · Gross margin 66%
Whose cash flow backs up their earnings? Business quality	93Backed	27 of 60	3 years 179% · Last year 145% · Free cash flow $263.2M
Which stocks are priced for perfection? Value	87Rich	50 of 60	Forward P/E 31× · EV / sales 9.3× · Expected EPS growth +14%

Go deeper on Stox

TECH’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open TECH on Stox ›All 16 types on Atlas ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see TECH’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›Health care stocks ›TMO · Thermo Fisher Scientific ›DHR · Danaher ›RGEN · Repligen ›AVTR · Avantor ›